Detalhe da pesquisa
1.
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes.
Am J Hematol
; 99(2): E32-E36, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994196
2.
Clinical Impact of Polymerase Chain Reaction-Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study.
Clin Infect Dis
; 77(1): 38-45, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905147
3.
Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects.
Ann Hematol
; 102(6): 1395-1408, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37119314
4.
BCR::ABL1 kinase domain mutation testing and clinical outcome in a nationwide chronic myeloid leukemia patient population.
Eur J Haematol
; 111(6): 938-945, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731314
5.
The wider perspective: twenty years of clinical trials in myelodysplastic syndromes.
Br J Haematol
; 196(2): 329-335, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34632583
6.
The evolution of the loss of life expectancy in patients with chronic myeloid leukaemia: a population-based study in the Netherlands, 1989-2018.
Br J Haematol
; 196(5): 1219-1224, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34865221
7.
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure.
N Engl J Med
; 381(24): 2315-2326, 2019 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826340
8.
A retrospective observational research study to describe the real-world use of bosutinib in patients with chronic myeloid leukemia in the United Kingdom and the Netherlands.
Eur J Haematol
; 109(1): 90-99, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35403752
9.
Older Patients with Acute Myeloid Leukemia Deserve Individualized Treatment.
Curr Oncol Rep
; 24(11): 1387-1400, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35653050
10.
Phosphotyrosine-based Phosphoproteomics for Target Identification and Drug Response Prediction in AML Cell Lines.
Mol Cell Proteomics
; 19(5): 884-899, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32102969
11.
Fatigue in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy: predictors and the relationship with physical activity.
Haematologica
; 106(7): 1876-1882, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32616528
12.
TRough versus AUC Monitoring of cyclosporine: A randomized comparison of adverse drug reactions in adult allogeneic stem cell recipients (TRAM study).
Eur J Haematol
; 107(3): 364-369, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34114691
13.
Bimodal expression of potential drug target CLL-1 (CLEC12A) on CD34+ blasts of AML patients.
Eur J Haematol
; 107(3): 343-353, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34053123
14.
RNA-based FLT3-ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML.
Blood
; 131(22): 2485-2489, 2018 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29669779
15.
Prospective validation of the prognostic relevance of CD34+CD38- AML stem cell frequency in the HOVON-SAKK132 trial.
Blood
; 141(21): 2657-2661, 2023 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898087
16.
Food-effect study of nilotinib in chronic myeloid leukaemia (NiFo study): Enabling dose reduction and relief of treatment burden.
Eur J Haematol
; 105(2): 148-155, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32243653
17.
Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib.
Eur J Clin Pharmacol
; 76(9): 1213-1226, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32488333
18.
The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA-identical sibling donors: results of the HOVON-107 study.
Transfusion
; 59(1): 316-324, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30548284
19.
Survival of early posthematopoietic stem cell transplantation relapse of myeloid malignancies.
Eur J Haematol
; 103(5): 491-499, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31411761
20.
Feasibility of and patients' perspective on nilotinib dried blood spot self-sampling.
Eur J Clin Pharmacol
; 75(6): 825-829, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30729257